Cetera Investment Advisers Amneal Pharmaceuticals, Inc. Transaction History
Cetera Investment Advisers
- $80.6 Billion
- Q3 2025
A detailed history of Cetera Investment Advisers transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 14,570 shares of AMRX stock, worth $169,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,570Holding current value
$169,594% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
257Shares Held
150MCall Options Held
357KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA18MShares$209 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...